DE60021059D1 - Hydrogelpartikel formulierungen - Google Patents

Hydrogelpartikel formulierungen

Info

Publication number
DE60021059D1
DE60021059D1 DE60021059T DE60021059T DE60021059D1 DE 60021059 D1 DE60021059 D1 DE 60021059D1 DE 60021059 T DE60021059 T DE 60021059T DE 60021059 T DE60021059 T DE 60021059T DE 60021059 D1 DE60021059 D1 DE 60021059D1
Authority
DE
Germany
Prior art keywords
methods
hydrogel
particular formulations
new compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60021059T
Other languages
English (en)
Other versions
DE60021059T2 (de
Inventor
H O'connor
Joseph Prestrelski
Yuh-Fun Maa
Andrew Muddle
Roderick Hafner
Terry Lee Burkoth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Research Ltd
Original Assignee
Powderject Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Research Ltd filed Critical Powderject Research Ltd
Application granted granted Critical
Publication of DE60021059D1 publication Critical patent/DE60021059D1/de
Publication of DE60021059T2 publication Critical patent/DE60021059T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60021059T 1999-02-03 2000-02-03 Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem Expired - Fee Related DE60021059T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11833499P 1999-02-03 1999-02-03
US118334P 1999-02-03
PCT/GB2000/000349 WO2000045792A1 (en) 1999-02-03 2000-02-03 Hydrogel particle formulations

Publications (2)

Publication Number Publication Date
DE60021059D1 true DE60021059D1 (de) 2005-08-04
DE60021059T2 DE60021059T2 (de) 2006-05-18

Family

ID=22377934

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021059T Expired - Fee Related DE60021059T2 (de) 1999-02-03 2000-02-03 Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem

Country Status (16)

Country Link
US (1) US7022313B2 (de)
EP (1) EP1146861B1 (de)
JP (1) JP2002536317A (de)
KR (1) KR100845769B1 (de)
CN (1) CN1230152C (de)
AT (1) ATE298562T1 (de)
AU (1) AU780397B2 (de)
BR (1) BR0007974A (de)
CA (1) CA2361555A1 (de)
DE (1) DE60021059T2 (de)
ES (1) ES2243229T3 (de)
IL (2) IL144597A0 (de)
MX (1) MXPA01007844A (de)
NZ (1) NZ513538A (de)
PT (1) PT1146861E (de)
WO (1) WO2000045792A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053160A1 (en) * 1999-03-08 2000-09-14 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US20050214227A1 (en) * 1999-03-08 2005-09-29 Powderject Research Limited Microparticle formulations for sustained-release of bioactive compounds
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
US20020051821A1 (en) * 2000-09-08 2002-05-02 Sung-Yun Kwon Aliginate particle formulation
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
US7943067B2 (en) * 2001-08-16 2011-05-17 Polytechnic Institute Of New York University Nanogels and their production using liposomes as reactors
GB2404865B (en) * 2001-09-11 2005-09-28 Caretek Medical Ltd Novel drug delivery technology
KR20050044523A (ko) * 2001-11-19 2005-05-12 벡톤 디킨슨 앤드 컴퍼니 입자 형태의 약제학적 조성물
IL163941A0 (en) * 2002-04-10 2005-12-18 Obschestvo S Ogranichennoy Otv Polyfunctional biocompatible hydrogel and method for the production thereof
EP1356826A1 (de) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Mikropartikel die Kohlenhydratkugeln enthalten an welche ein Allergen kovalent gebunden sind
GB0300008D0 (en) * 2003-01-02 2003-02-05 Optinose As Delivery devices
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
ITRM20040168A1 (it) * 2004-04-01 2004-07-01 Sigma Tau Ind Farmaceuti Composizione a rilascio modificato ph dipendente.
KR100624450B1 (ko) * 2004-12-10 2006-09-18 삼성전자주식회사 히드로겔을 이용한 생물분자의 분리 및 정제 방법
KR100624452B1 (ko) 2004-12-21 2006-09-18 삼성전자주식회사 고정화된 히드로겔 또는 ｐｅｇ－히드로겔 공중합체를이용한 핵산의 분리 및 정제 방법
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
EP1981338A2 (de) * 2006-01-13 2008-10-22 Advanced Bionutrition Corporation Produktionssystem mit kontinuierlicher sprühnebelaufnahme
EP2007358A4 (de) * 2006-04-04 2012-01-25 Stc Unm Quellbare partikel für wirkstofffreisetzung
WO2007144894A1 (en) * 2006-06-15 2007-12-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Hydrocolloid carrier beads with inert filler material
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
JP2008096503A (ja) * 2006-10-06 2008-04-24 Toshiba Corp 粉末状感光性組成物の製造方法、感光性組成物およびこの感光性組成物から形成された光記録媒体
US8273770B2 (en) 2007-07-21 2012-09-25 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
US8093038B2 (en) * 2007-09-17 2012-01-10 Illinois Institute Of Technology Apparatus and method for encapsulating pancreatic cells
US9468607B2 (en) * 2007-10-09 2016-10-18 Washington University Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
CN101868180A (zh) 2007-10-09 2010-10-20 圣路易斯华盛顿州立大学 成像粒子
US8293510B2 (en) 2007-11-16 2012-10-23 University Of Kansas Method of preparing a hydrogel network encapsulating cells
JP2011504505A (ja) 2007-11-21 2011-02-10 デコード ジェネティクス イーエイチエフ 肺および心血管障害を治療するためのビアリールｐｄｅ４抑制剤
JP5501251B2 (ja) 2008-01-11 2014-05-21 アルバニー モレキュラー リサーチ， インコーポレイテッド Ｍｃｈ拮抗薬としての（１−アジノン）置換ピリドインドール類
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
EP2589392B1 (de) * 2008-03-05 2016-11-30 Sanofi Pasteur Stabilisierungsverfahren für eine adjuvanshaltige Impfstoffzusammensetzung
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
BRPI1007350B8 (pt) 2009-01-26 2021-05-25 Israel Institute For Biological Res compostos espiro heterocíclicos bicíclicos
KR101742332B1 (ko) * 2009-04-20 2017-05-31 갈렌바이오 인코포레이티드 생체분자로 세포를 형질감염시키기 위한 조성물
CA3042067C (en) 2009-12-15 2022-10-18 Incept, Llc Implants and biodegradable fiducial markers
US9764043B2 (en) 2009-12-17 2017-09-19 Washington University Antithrombotic nanoparticle
US9808500B2 (en) 2009-12-17 2017-11-07 Washington University Antithrombotic nanoparticle
PT2525815E (pt) * 2010-01-24 2015-03-05 Novartis Ag Micropartículas de polímero biodegradável irradiadas
CN103096874A (zh) 2010-04-15 2013-05-08 华盛顿大学 前药组合物、前药纳米粒子及其使用方法
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク． メトプロロールを含むアルコール耐性持続放出性経口剤形
JP6042815B2 (ja) 2010-10-08 2016-12-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
US8946194B2 (en) 2010-10-08 2015-02-03 Board Of Regents, University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
CN103167868B (zh) * 2010-10-14 2016-08-03 株式会社爱茉莉太平洋 包覆有脂质的水凝胶粒子及其制备方法
WO2012148953A1 (en) * 2011-04-25 2012-11-01 Stc.Unm Solid compositions for pharmaceutical use
KR101255520B1 (ko) * 2011-10-28 2013-04-23 한국과학기술원 이중충하이드로젤 미세입자의 비등방성 부품을 이용한 미세수송체의 제조방법
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US11426571B2 (en) * 2016-11-18 2022-08-30 Industry-Academic Cooperation Foundation, Yonsei University Microneedle array with composite formulation, and method for manufacturing same
WO2018165327A1 (en) 2017-03-08 2018-09-13 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
KR102129986B1 (ko) * 2018-08-30 2020-07-03 포항공과대학교 산학협력단 일산화질소 감응성을 갖는 아크릴아마이드계 고분자를 포함하는 염증성 질환 예방 또는 치료용 약학 조성물
US10799564B1 (en) * 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
SE456486B (sv) * 1987-03-27 1988-10-10 Ralf Andersson Sett och anordning for uppdelning av en smelta i droppar
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5041292A (en) * 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
EP0500799B1 (de) 1989-11-16 1998-01-14 Duke University Transformation von tierischen Hautzellen mit hilfe von Partikeln
DK0454044T3 (da) * 1990-04-25 1996-04-22 Hoechst Ag Farmakologisk præparat indeholdende polyelektrolytkomplekser på mikropartikelform og mindst et virksomt stof
GB9014871D0 (en) * 1990-07-05 1990-08-22 Erba Carlo Spa Drug delivery system for administering growth factor
AU5547594A (en) 1992-11-03 1994-05-24 Secretech, Inc. Microcrystalline cellulose as an immune adjuvant
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
EP0727984B1 (de) * 1993-11-18 2003-06-25 Sirtex Medical Limited Zubereitung mit gesteuerter freisetzung
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
EP0788386B1 (de) 1994-10-24 1999-01-13 PowderJect Research Limited Nadellose spritze
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
GB9605690D0 (en) 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
AU4940197A (en) 1996-09-26 1998-04-17 Wanzl Metallwarenfabrik Gmbh Device and method for the purchasing of goods
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
EP0888790A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Vorrichtung zur Abgabe von Medikamententeilchen
EP0888791A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Spritze und dafür geeignete Medikamentenkapsel
NZ510923A (en) 1998-09-04 2003-09-26 Powderject Res Ltd Monitoring methods using particle delivery methods
WO2000014547A1 (en) 1998-09-04 2000-03-16 Powderject Research Limited Immunodiagnostics using particle delivery methods
US5952232A (en) 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
DE69925293T2 (de) 1998-10-01 2006-01-26 Powderject Research Ltd. Sprühbeschichtete mikropartikel für nadellose spritzen
AU765429B2 (en) 1999-01-22 2003-09-18 Powderject Research Limited Method of enhancing needleless transdermal powdered drug delivery

Also Published As

Publication number Publication date
JP2002536317A (ja) 2002-10-29
MXPA01007844A (es) 2005-06-06
US7022313B2 (en) 2006-04-04
WO2000045792A1 (en) 2000-08-10
CA2361555A1 (en) 2000-08-10
AU2309200A (en) 2000-08-25
KR100845769B1 (ko) 2008-07-11
AU780397B2 (en) 2005-03-17
KR20010101994A (ko) 2001-11-15
EP1146861B1 (de) 2005-06-29
EP1146861A1 (de) 2001-10-24
NZ513538A (en) 2004-02-27
CN1230152C (zh) 2005-12-07
CN1345232A (zh) 2002-04-17
PT1146861E (pt) 2005-10-31
US20020061336A1 (en) 2002-05-23
BR0007974A (pt) 2001-10-30
DE60021059T2 (de) 2006-05-18
ES2243229T3 (es) 2005-12-01
ATE298562T1 (de) 2005-07-15
IL144597A0 (en) 2002-05-23
WO2000045792A8 (en) 2001-11-29
IL144597A (en) 2007-03-08

Similar Documents

Publication Publication Date Title
DE60021059D1 (de) Hydrogelpartikel formulierungen
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
HK1036970A1 (en) Compounds and compositions for delivering active agents.
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
ATE391708T1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
IL140930A0 (en) Compounds and compositions for delivering active agents
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
EP1226104A4 (de) Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE262329T1 (de) Formulierungen und verfahren zur verminderung der toxizität von anti-neoplastischen mitteln
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
ATE292453T1 (de) Antivirale arznei
DE69521693T2 (de) Taxanderivate enthaltende arzneizubereitungen
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
JO2506B1 (en) Dosage titration device in hydrofluoroalkan propellants
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
CO5200854A1 (es) Formulaciones farmaceuticas orales en capsulas de gelatina de hidroxipropilmetil celulosa que comprenden un derivado de camptotecina dentro de una matriz semisolida de polietilenglicol
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee